METPRAM metoclopramide hydrochloride 5 mg film coated tablets blister pack

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

metoclopramide hydrochloride, Quantity: 5 mg

제공처:

Ipca Pharma (Australia) Pty Ltd

INN (국제 이름):

metoclopramide hydrochloride

약제 형태:

Tablet, film coated

구성:

Excipient Ingredients: maize starch; pregelatinised maize starch; titanium dioxide; microcrystalline cellulose; macrogol 6000; purified talc; hypromellose; stearic acid; colloidal anhydrous silica

관리 경로:

Oral

패키지 단위:

20, 10, 30, 125, 100, 60, 50, 150, 25

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

In Adults (20 years and over): As an adjunct to X-ray examination of the stomach and duodenum. To assist in intestinal intubation. To control nausea and vomiting associated with the following conditions: intolerance to essential drugs possessing emetic properties; uraemia; radiation sickness; malignant disease; postoperative vomiting; labour; infectious diseases. There is no clear benefit in motion sickness or other labyrinth disturbances. Metoclopramide hydrochloride has been found useful in the management of gastric retention after gastric surgery. Metoclopramide hydrochloride may be useful in the treatment of diabetic gastroparesis of mild to moderate severity. Once control of diabetes has been established by diet and/or insulin, metoclopramide hydrochloride should be discontinued.,Young Adults: The use of metoclopramide hydrochloride in patients under 20 years should be restricted to the following situations: Severe intractable vomiting of known cause. Vomiting associated with radiotherapy and intolerance to cytotoxic drugs. As an aid to gastrointestinal intubation

제품 요약:

Visual Identification: White to off-white, circular, biconvex film-coated tablets plain on both sides.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2015-12-17

환자 정보 전단

Metpram
CMI,
Version 00
Page 1 of 7
METPRAM 5 MG & 10 MG
_Metoclopramide hydrochloride anhydrous _
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some common questions about Metpram. It does not
contain all the
available information. It does not take the place of talking to your
doctor or pharmacist. All
medicines have risks and benefits. Your doctor has weighed the risks
of you taking
Metpram against the benefits they expect it will have for you.
IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR
OR PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again.
WHAT METPRAM IS USED FOR
In adults over 20 years this medicine is used to:

treat nausea and vomiting caused by infectious diseases, kidney
disease, child birth,
other medications, cancer, or following surgery, chemotherapy or
radiation treatment.

activate stomach contractions in conditions where there is a need to
encourage normal
passage of food through the stomach and intestines.

with X-rays to help diagnose problems of the stomach and/or
intestines.

help with passing tubes into the intestine.
In young adults and children over 1 year if age this medicine is used
to:

treat severe vomiting of known cause or following chemotherapy or
radiation treatment.

help with passing tubes into the intestine.
This medicine works by blocking the action of a chemical in the brain
which causes nausea
and vomiting. It also acts in the stomach and upper intestine to
increase muscle contractions
ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS
BEEN
PRESCRIBED FOR YOU.
Your doctor may have prescribed it for another reason.
BEFORE YOU TAKE METPRAM
_ _
_WHEN YOU MUST NOT TAKE IT _
DO NOT TAKE METPRAM IF YOU HAVE AN ALLERGY TO:

any medicine containing Metoclopramide

any of the ingredients listed at the end of this leaflet.
Some of the symptoms of an allergic reaction may include:

shortness of breath

wheezing or difficulty breathing
Metpram
CMI,
Version 00